Effect of Traditional Chinese Medicine fumigation combined with the meibomian gland squeezer for treatment of dry eye associated with meibomian gland dysfunction

注册号:

Registration number:

ITMCTR2200005506

最近更新日期:

Date of Last Refreshed on:

2022-01-05

注册时间:

Date of Registration:

2022-01-05

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

中药熏蒸联合睑板腺按摩镊治疗睑板腺功能障碍性干眼的临床研究

Public title:

Effect of Traditional Chinese Medicine fumigation combined with the meibomian gland squeezer for treatment of dry eye associated with meibomian gland dysfunction

注册题目简写:

English Acronym:

研究课题的正式科学名称:

上海市卫健委临床研究专项

Scientific title:

Shanghai Municipal Commission of health and family planning (grant no. 20194Y0246)

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

20194Y0246

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2200055299 ; ChiMCTR2200005506

申请注册联系人:

王大虎

研究负责人:

王大虎

Applicant:

Da-Hu Wang

Study leader:

Da-Hu Wang

申请注册联系人电话:

Applicant telephone:

+86 13764260833

研究负责人电话:

Study leader's telephone:

+86 13764260833

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

wangdahu2008@163.com

研究负责人电子邮件:

Study leader's E-mail:

wangdahu2008@163.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

上海市徐汇区宛平南路725号

研究负责人通讯地址:

上海市徐汇区宛平南路725号

Applicant address:

No.725 South Wanping Road, Xuhui District, Shanghai, China

Study leader's address:

No.725 South Wanping Road, Xuhui District, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

200032

研究负责人邮政编码:

Study leader's postcode:

200032

申请人所在单位:

上海中医药大学附属龙华医院

Applicant's institution:

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2021LCSY077

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

上海中医药大学附属龙华医院医学伦理委员会

Name of the ethic committee:

Ethics Committee of Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2021/4/29 0:00:00

伦理委员会联系人:

陈晓云

Contact Name of the ethic committee:

Xiao-Yun Chen

伦理委员会联系地址:

上海市徐汇区宛平南路725号

Contact Address of the ethic committee:

No.725 South Wanping Road, Xuhui District, Shanghai, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海中医药大学附属龙华医院

Primary sponsor:

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

上海市徐汇区宛平南路725号

Primary sponsor's address:

No.725 South Wanping Road, Xuhui District, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海中医药大学附属龙华医院

具体地址:

上海市徐汇区宛平南路725号

Institution
hospital:

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Address:

No.725 South Wanping Road, Xuhui District, Shanghai, China

经费或物资来源:

上海市卫健委临床研究专项

Source(s) of funding:

Shanghai Municipal Commission of health and family planning (grant no. 20194Y0246)

研究疾病:

睑板腺功能障碍;干眼

研究疾病代码:

Target disease:

Meibomian Gland Dysfunction; Dry eye

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

通过观察中药熏蒸联合睑板按摩镊治疗睑板腺功能障碍性干眼的疗效,为临床提供一种安全有效、较优的治疗方案。

Objectives of Study:

To investigate the efficacy of Traditional Chinese Medicine fumigation combined with the meibomian gland squeezer for treatment of dry eye associated with meibomian gland dysfunction

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

(1)符合MGD性干眼的诊断标准; (2)年龄18岁—75周岁; (3)有能力理解并签署知情同意书,愿意并能够配合研究要求。

Inclusion criteria

(1) Compliance with diagnostic criteria of dry eye associated with meibomian gland dysfunction; (2)Aged 18 to 75 years; (3)To be willing and able to cooperate with study requirements; Agreed to use a reliable form of contraception if of childbearing potential

排除标准:

(1)眼部感染者; (2)合并结膜、角膜病变、青光眼等疾病; (3)眼睑疾病及眼球突出者; (4)有眼部手术史且还未完全恢复者; (5)妊娠和哺乳期妇女; (6)对药物过敏者; (7)正在参加其他药物临床试验或应用其他眼部药物者; (8)有精神疾病或者全身状态差不能配合检查者等。

Exclusion criteria:

(1) Ocular infection; (2) Active ocular diseases, such as conjunctivitis, keratopathy, glaucoma and other diseases; (3) Eyelid disease and eyeball protrusion; (4) Had a history of intraocular surgery or ocular surgery, not completely recovered; (5) Pregnant and lactating women; (6) Active ocular allergies; (7) Participating in clinical trials of other drugs or using other eye drugs; (8) Persons with mental illness or poor general condition who cannot cooperate with the inspection, etc.

研究实施时间:

Study execute time:

From 2022-01-01

To      2022-12-31

征募观察对象时间:

Recruiting time:

From 2022-01-12

To      2022-12-31

干预措施:

Interventions:

组别:

治疗组

样本量:

50

Group:

Treatment

Sample size:

干预措施:

中药熏蒸联合睑板腺按摩镊

干预措施代码:

Intervention:

Traditional Chinese Medicine fumigation combined with the meibomian gland squeezer

Intervention code:

组别:

对照组

样本量:

50

Group:

Control

Sample size:

干预措施:

睑板腺按摩镊

干预措施代码:

Intervention:

The meibomian gland squeezer

Intervention code:

样本总量 Total sample size : 100

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

上海市

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海中医药大学附属龙华医院

单位级别:

三级甲等

Institution/hospital:

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Level of the institution:

Tertiary A hospital

测量指标:

Outcomes:

指标中文名:

角膜荧光染色

指标类型:

次要指标

Outcome:

corneal fluorescein staining(CFS)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

泪膜破裂时间

指标类型:

主要指标

Outcome:

tear break-up time, BUT

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

泪液分泌试验

指标类型:

次要指标

Outcome:

schirmer scores with no anaesthetic(schirmer I test,SIT)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

眼表疾病指数

指标类型:

次要指标

Outcome:

Ocular surface disease index(OSDI)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

眼部症状评分

指标类型:

次要指标

Outcome:

ocular symptom scores

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

分泌睑脂的能力

指标类型:

次要指标

Outcome:

meibum expressibility

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

分泌睑脂的质量

指标类型:

次要指标

Outcome:

the quality of expressed meibum

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

Not applicable

组织:

Sample Name:

Not applicable

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 18
Min age years
最大 75
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

由统计学专家通过spss 25.0产生随机数。

Randomization Procedure (please state who generates the random number sequence and by what method):

By using computer-generated randomization.

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2022年12月试验完成后将试验成果发表在学术期刊上

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The results of the test will be published in the open access to academic journals in Dec 2022.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

上海中医药大学附属龙华医院医院管理信息系统(THIS 5.0)

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Hospital management information system of Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine (This 5.0)

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above